Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 06 symbols : Nvs save search
Global Cancer Immunotherapy Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-04-06 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 4.21%
H: 0.0%
C: -0.61%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 1.45%
H: 0.46%
C: 0.19%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -1.11%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.39%
H: 0.53%
C: 0.44%
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
GSK | News | $40.995 1.0% 590K
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
LLY | News | $742.04 1.46% 540K
|
Health Technology
|
| O: -0.27%
H: 2.95%
C: 1.12%
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 0.05%
H: 2.52%
C: 2.49%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 1.74%
H: 0.0%
C: 0.0%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: 0.35%
H: 2.64%
C: 2.45%
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: -0.29%
H: 1.42%
C: 0.98%
immunotherapy cancer market
Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
Published: 2022-04-06 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 0.37%
H: 0.06%
C: 0.06%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.78%
H: 2.05%
C: 2.01%
solutions collaboration
FDA approves Novartis Vijoice® (alpelisib) as first and only treatment for select patients with PIK3CA-Related Overgrowth Spectrum (PROS)
Published: 2022-04-06 (Crawled : 01:00) - globenewswire.com
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 0.37%
H: 0.06%
C: 0.06%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.78%
H: 2.05%
C: 2.01%
vijoice treatment fda novartis
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
LOCL | $3.33 27.59% 43K
|
Your saved searches
Save your searches and get alerts when important news are released.